Clinical trial
Predictors for Poststroke Outcomes: the Tel Aviv Brain Acute Stroke Cohort (TABASCO) Study
NCT01926691 is registered in ClinicalTrials.gov with Eli Sprecher, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictors for Poststroke Outcomes: the Tel Aviv Brain Acute Stroke Cohort (TABASCO) Study
- Lead sponsor
- Eli Sprecher, MD
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2008
- Completion date
- December 31, 2015
- Enrollment
- 575 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease, brain ischemia, cerebrovascular disorders, dementia, stroke